Levobunolol ophthalmic and Moxetumomab pasudotox
Determining the interaction of Levobunolol ophthalmic and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: levobunolol ophthalmic
Brand name: Betagan, Akbeta, Levobunolol, Betagan C-Cap
Synonyms: Levobunolol
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Levobunolol ophthalmic-Moxetumomab Pasudotox-tdfk
- Levobunolol ophthalmic-Moxetumomab pasudotox-tdfk Intravenous
- Levobunolol ophthalmic-Moxifloxacin
- Levobunolol ophthalmic-Moxifloxacin (Systemic)
- Levobunolol ophthalmic-Moxifloxacin Hydrochloride
- Levobunolol ophthalmic-Moxifloxacin Injection
- Moxetumomab pasudotox-Levocarnitine
- Moxetumomab pasudotox-Levocarnitine Capsules and Tablets
- Moxetumomab pasudotox-Levocarnitine Injection
- Moxetumomab pasudotox-Levocarnitine Injection Solution
- Moxetumomab pasudotox-Levocarnitine Oral Solution
- Moxetumomab pasudotox-Levocarnitine Oral, Intravenous